trending Market Intelligence /marketintelligence/en/news-insights/trending/yauruo9fz0owjhmpsym-3a2 content esgSubNav
In This List

Biocure Technology director resigns; replacement named

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Biocure Technology director resigns; replacement named

Canada's Biocure Technology Inc. said Marco Nonni resigned as a director.

Nonni joined the company's board in April, and will continue working with Biocure Technology on a consulting basis.

The company appointed Hans Frykman to replace Nonni, effective Sept. 4.

Frykman is medical director at Neurocode Labs and UBC Diagnostic Services Lab.

Biocure Technology develops and commercializes biosimilar pharmaceutical products in South Korea.